Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Koji Haratani, M.D., Ph.D.

Concepts (190)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung28202452952.130 Why?
Lung Neoplasms302024132181.560 Why?
Receptor, erbB-3620211451.290 Why?
Neoplasms, Unknown Primary120191020.630 Why?
Lymphocytes, Tumor-Infiltrating3202010600.580 Why?
Biomarkers, Pharmacological120181600.570 Why?
Antibodies, Monoclonal5202491070.560 Why?
Immune System Diseases120182560.510 Why?
Immunoconjugates220208570.510 Why?
Drug Resistance, Neoplasm10202351660.480 Why?
Neoplasms, Experimental1202012290.480 Why?
Acrylamides120152580.460 Why?
Tumor Microenvironment5202336950.450 Why?
Protein Kinase Inhibitors11202256130.450 Why?
Pyrimidines2202129600.300 Why?
Gene Expression Regulation, Neoplastic3202083560.300 Why?
Camptothecin220215910.280 Why?
Mutation152023296270.270 Why?
Carcinoma, Squamous Cell4202139850.260 Why?
Receptor, erbB-24202124670.250 Why?
Proto-Oncogene Proteins p21(ras)2202216900.230 Why?
Antineoplastic Combined Chemotherapy Protocols72022115840.230 Why?
Exodeoxyribonucleases120241860.210 Why?
Xenograft Model Antitumor Assays6202035290.210 Why?
Paget Disease, Extramammary12021460.190 Why?
Genital Neoplasms, Male12021680.190 Why?
Antineoplastic Agents62020135860.190 Why?
Selective Estrogen Receptor Modulators120211300.190 Why?
Proto-Oncogene Proteins c-met220225720.180 Why?
Cell Line, Tumor102024166670.180 Why?
Gene Amplification2202210830.180 Why?
Proto-Oncogene Proteins3202344870.180 Why?
Neuregulin-1220191350.170 Why?
Monitoring, Immunologic12019950.170 Why?
Pneumonia2202121160.170 Why?
Aged, 80 and over102024575860.170 Why?
Adenocarcinoma2201763000.160 Why?
Neoplasm Staging22024110780.160 Why?
Hepatitis120202300.150 Why?
Neoplasms42024217150.150 Why?
Kaplan-Meier Estimate2201964600.150 Why?
Humans4620247466300.150 Why?
Carbazoles120192200.150 Why?
Melanoma, Experimental120205600.150 Why?
Tamoxifen120219570.140 Why?
Aged1920241643830.140 Why?
Borrelia Infections12016170.140 Why?
Maytansine12016840.140 Why?
Patient Selection2201941940.140 Why?
Borrelia12016650.130 Why?
Middle Aged1920242146180.130 Why?
Extracellular Signal-Regulated MAP Kinases120186110.130 Why?
Cholangitis120171090.130 Why?
Signal Transduction52024231540.130 Why?
Lyme Neuroborreliosis12016500.130 Why?
Protein-Tyrosine Kinases2202324210.130 Why?
Phosphoproteins1202424050.130 Why?
Meningitis, Bacterial120162200.120 Why?
Carboplatin320228020.120 Why?
Retrospective Studies112023783130.120 Why?
Immunomodulation120185410.120 Why?
Disease Progression32022133170.110 Why?
Female2220243824500.110 Why?
Japan3202112670.110 Why?
Prognosis82021290790.110 Why?
Esophageal Neoplasms1202216170.100 Why?
Indoles1202018060.100 Why?
Histocompatibility Antigens Class I1201813380.100 Why?
Intercellular Signaling Peptides and Proteins1201916500.100 Why?
Treatment Outcome82021637320.100 Why?
Receptor Protein-Tyrosine Kinases1201916410.100 Why?
Male2020243514200.100 Why?
Proto-Oncogene Proteins B-raf1202120290.100 Why?
Cisplatin3202216370.100 Why?
Adult1120242151920.090 Why?
Piperazines1202124720.090 Why?
Fatal Outcome1201518250.090 Why?
T-Lymphocytes, Cytotoxic1201818010.090 Why?
Piperidines1201916370.090 Why?
Quinazolines1201613550.090 Why?
Disease-Free Survival2201767890.090 Why?
Renal Dialysis1201916950.090 Why?
Lymphocytes1201725890.090 Why?
Leukocytes1201720130.080 Why?
Chemotherapy, Adjuvant1201834780.080 Why?
Pyridines1202128440.080 Why?
Mice92024802510.080 Why?
Immunohistochemistry22019110500.080 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase120081270.080 Why?
Dyneins120081250.080 Why?
Membrane Proteins1202477860.070 Why?
Fluorouracil2202216030.070 Why?
Stomach Neoplasms1201613610.070 Why?
Head and Neck Neoplasms1202128300.070 Why?
Follow-Up Studies42021387710.070 Why?
Cell Transformation, Neoplastic1201528030.060 Why?
Survival Rate42021126450.060 Why?
Neutrophils1201737090.060 Why?
Animals1020241665580.060 Why?
Paclitaxel2202116930.060 Why?
Cytoplasm1200815200.060 Why?
Ligands2202232690.060 Why?
Gene Expression Profiling1201993200.060 Why?
Tumor Cells, Cultured2202161420.050 Why?
Microtubule-Associated Proteins1200810820.050 Why?
Neoplasm Recurrence, Local1202191930.050 Why?
Lung1202199180.050 Why?
Prospective Studies22024532530.050 Why?
Immunotherapy1201845930.050 Why?
Oxycodone120231370.050 Why?
5'-Nucleotidase120221570.050 Why?
Catechol O-Methyltransferase120232470.050 Why?
Breast Neoplasms22019207630.050 Why?
Interferons120247010.040 Why?
Genes, ras120226540.040 Why?
Time Factors22021396220.040 Why?
Phenotype12017162610.040 Why?
Colorectal Neoplasms1201967480.040 Why?
Taxoids120226630.040 Why?
Plasma Exchange120201550.040 Why?
HT29 Cells120191910.040 Why?
Clinical Trials, Phase II as Topic120216270.040 Why?
Albumins120215630.040 Why?
Bronchoalveolar Lavage Fluid120217600.040 Why?
Cell Proliferation32020103110.040 Why?
Morphine120236500.040 Why?
High-Throughput Nucleotide Sequencing2202136140.040 Why?
Apoptosis3202094470.040 Why?
DNA Topoisomerases, Type I120181090.040 Why?
Topoisomerase I Inhibitors12018760.040 Why?
HCT116 Cells120194000.040 Why?
CD8-Positive T-Lymphocytes2202245160.040 Why?
Oncogene Protein v-akt120161290.040 Why?
Multicenter Studies as Topic1202116790.030 Why?
Inhibitor of Apoptosis Proteins120161980.030 Why?
Tumor Burden1202118820.030 Why?
Drug Compounding120172470.030 Why?
Genetic Predisposition to Disease12017174450.030 Why?
Ceftriaxone120161700.030 Why?
Bronchoscopy120218870.030 Why?
Cohort Studies12018405340.030 Why?
Carrier Proteins1200849280.030 Why?
Killer Cells, Natural1202421700.030 Why?
Immunologic Factors1202415670.030 Why?
Injections, Intravenous1201713760.030 Why?
Doxycycline120163340.030 Why?
Safety1201911490.030 Why?
Lymphatic Metastasis1202129190.030 Why?
Drug Administration Schedule1202148830.030 Why?
Proto-Oncogene Proteins c-akt1202124350.030 Why?
Mice, Nude1201935830.030 Why?
Phosphatidylinositol 3-Kinases1202128690.030 Why?
Facial Paralysis120163440.030 Why?
Single-Cell Analysis1202222770.020 Why?
MAP Kinase Signaling System1201814810.020 Why?
Neoadjuvant Therapy1202227880.020 Why?
Down-Regulation1201829080.020 Why?
Sequence Analysis, DNA1202147090.020 Why?
Antibodies, Bacterial1201614420.020 Why?
Mice, Inbred BALB C1201961020.020 Why?
Disease Models, Animal22019178690.020 Why?
Biopsy1202167340.020 Why?
Fluorescence Recovery After Photobleaching12008530.020 Why?
Survival Analysis12021101380.020 Why?
Cell Survival1201957640.020 Why?
Genetic Testing1202134780.020 Why?
Genotype12023127880.020 Why?
Multivariate Analysis12021120210.020 Why?
Pain1202349820.020 Why?
Genomics1202356950.020 Why?
Phosphorylation1201882940.020 Why?
Antibodies, Neutralizing1201718970.020 Why?
Analgesics, Opioid1202336780.020 Why?
Gene Expression1201975900.020 Why?
Molecular Targeted Therapy1201827820.020 Why?
Drug Therapy, Combination1201664630.020 Why?
Tubulin120086970.020 Why?
Biological Transport1200820790.010 Why?
Incidence12021208200.010 Why?
Microtubules1200810780.010 Why?
Mice, Inbred C57BL12020216000.010 Why?
Severity of Illness Index12020155550.010 Why?
Liver1201773820.010 Why?
Recombinant Fusion Proteins1200837240.010 Why?
Risk Assessment12021234640.010 Why?
Swine1200858730.010 Why?
Anti-Bacterial Agents1201672290.010 Why?
Cell Line12008156420.010 Why?
Risk Factors12021724470.010 Why?
Neurons1200892920.010 Why?
Haratani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (190)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.